Skip to content
Study details
Enrolling now

A Randomized, Double Blind, Placebo Controlled Clinical Trial to Examine the Benefits of an Oral Product in Women With Menopausal Symptoms Including Vasomotor Symptoms (VMS)

Olly, PBC
NCT IDNCT07033013ClinicalTrials.gov data as of Apr 2026
Target enrollment

40

Study length

about 25 days

Ages

40–65

Sex

Female only

Locations

1 site in CA

What this study is about

This trial is testing a dietary supplement for women experiencing menopausal symptoms like hot flashes. Participants will take either the supplement or a placebo daily for 25 days while tracking their symptoms using diaries and questionnaires. The goal is to see if the supplement helps reduce these symptoms.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Dietary Supplement with actives
  • 2.Placebo

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

dietary supplement

Endpoints

Secondary: Improvement of overall daily menopausal vasomotor symptoms